Genomics Analysis & Statistics, March 2015

24/7 Customer Support

Talk to Louis

+1 718 618 4302

1-30 of about 800 reports

Purchase Reports From Reputable Market Research Publishers

Proteomics: Technologies and Global Markets

Proteomics: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • February 2015
  • by BCC Research

REPORT HIGHLIGHTS The global proteomics market was valued at nearly $5.1 billion in 2014 and is growing at a compound annual growth rate (CAGR) of 18.0% to reach a forecast value of $11.6 billion by 2019. ...

  • Industries : Genomics
  • Countries : World
Renal Biomarkers: Technologies and Global Markets

Renal Biomarkers: Technologies and Global Markets

  • $ 6 650
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The in vitro diagnostic renal biomarker market was valued at $771 million in 2013 and $812 million in 2014. The market is expected to reach $1.1 billion by 2019, a compound annual growth ...

  • Industries : Genomics
  • Countries : World
Molecular Weight Marker Market by Products, Type, Application, & End User - Global Forecast to 2019

Molecular Weight Marker Market by Products, Type, Application, & End User - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • February 2015
  • by MarketsandMarkets

The global molecular weight markers market comprises of DNA, Protein and RNA markers. The molecular weight markers market is further divided on the basis of type and size. The molecular weight markers ...

  • Industries : Office Supply and Stationery, Office Goods, Biotechnology, Genomics
  • Countries : World
Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019

Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019

  • $ 4 650
  • Industry report
  • February 2015
  • by MarketsandMarkets

The global molecular weight markers market comprises of DNA, Protein and RNA markers. The molecular weight markers market is further divided on the basis of type and size. The molecular weight markers ...

  • Industries : Office Supply and Stationery, Office Goods, Biotechnology, Genomics
  • Countries : World
IVD (In Vitro Diagnostic) Testing World Markets

IVD (In Vitro Diagnostic) Testing World Markets

  • $ 4 500
  • Industry report
  • January 2015
  • by TriMark Publications

In vitro diagnostic (IVD) testing is experiencing a revival fueled by a combination of technological improvements, cost pressures, reimbursement changes, rapid growth in molecular diagnostics and increasing ...

  • Industries : Diagnostics, Diagnostics, In Vitro Diagnostic, In Vitro Diagnostic, Medical Devices
  • Countries : World
Next Generation Sequencing (NGS) Markets 2015

Next Generation Sequencing (NGS) Markets 2015

  • $ 4 200
  • Industry report
  • January 2015
  • by Kalorama Information

No business planner in biotechnology or diagnostic equipment or services can ignore the trend of sequencing, and particularly next-generation sequencing. This technology has enabled a wide scope of research ...

  • Industries : Genomics, Diagnostics, Diagnostics
Biomarker - World Panorama

Biomarker - World Panorama

  • $ 3 750
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : World
Growth Drivers for Biomarkers in Healthcare : Managing Success in the Biomarker Industry - Challenges and Opportunities

Growth Drivers for Biomarkers in Healthcare : Managing Success in the Biomarker Industry - Challenges and Opportunities

  • $ 3 500
  • Industry report
  • March 2015
  • by Frost & Sullivan

Key Findings •The global biomarkers market was estimated at $ x billion in 2014 and is expected to reach $ x billion in 2020, growing at a robust CAGR of x % (2014–2020). •North America is the ...

  • Industries : Genomics
Biomarker - European Panorama

Biomarker - European Panorama

  • $ 3 125
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : Europe
Biomarker - North American Panorama

Biomarker - North American Panorama

  • $ 3 125
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : North America
Biomarker - Asian Panorama

Biomarker - Asian Panorama

  • $ 3 125
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : Asia
Global qPCR and dPCR Market 2015-2019

Global qPCR and dPCR Market 2015-2019

  • $ 3 000
  • Industry report
  • January 2015
  • by Infiniti Research Limited

About qPCR and dPCR qPCR (Real-time Polymerase Chain Reaction) and dPCR (Digital Polymerase Chain Reaction) are the advanced PCR technologies that provide higher accuracy and reproducibility in nucleic ...

  • Industries : Genomics
  • Countries : World
Global Gene Expression Market 2015-2019

Global Gene Expression Market 2015-2019

  • $ 3 000
  • Industry report
  • December 2014
  • by Infiniti Research Limited

About Gene Expression Gene expression is the biological process where genetic information is used for the synthesis of a functional gene product, either RNA or protein. Gene expression products allow researchers ...

  • Industries : Genomics
  • Countries : World
Global Digital PCR (dPCR) Market 2015-2019

Global Digital PCR (dPCR) Market 2015-2019

  • $ 2 500
  • Industry report
  • February 2015
  • by Infiniti Research Limited

About Digital PCR Advanced dPCR (Digital PCR) technology provides higher accuracy and reproducibility than traditional PCR technology in the amplification and analysis of nucleic acids. The dPCR technology ...

  • Industries : Genomics
  • Countries : World
Global Cancer Biomarkers Market 2015-2019

Global Cancer Biomarkers Market 2015-2019

  • $ 2 500
  • Industry report
  • January 2015
  • by Infiniti Research Limited

About Cancer Biomarkers Biomarkers are molecules present in the blood, other body fluids such as serum, urine, or in tissue that are indicators of a disease or abnormal conditions. Biomarkers are mostly ...

  • Industries : Genomics, Pathology
  • Countries : World
Global Prenatal and Newborn Genetic Testing Market 2015-2019

Global Prenatal and Newborn Genetic Testing Market 2015-2019

  • $ 2 500
  • Industry report
  • December 2014
  • by Infiniti Research Limited

About Prenatal and Newborn Genetic Testing Prenatal and newborn genetic testing involves genetic testing before and after birth. Prenatal testing helps detect changes in the fetus before birth. It can ...

  • Industries : Genomics
  • Countries : World
Myotonic Dystrophy - Pipeline Review, H1 2015

Myotonic Dystrophy - Pipeline Review, H1 2015

  • $ 2 000
  • Industry report
  • January 2015
  • by Global Markets Direct

Myotonic Dystrophy - Pipeline Review, H1 2015 Summary Global Markets Direct’s, ‘Myotonic Dystrophy - Pipeline Review, H1 2015’, provides an overview of the Myotonic Dystrophy’s therapeutic pipeline. ...

  • Industries : Genomics, Biotechnology
  • Countries : United States
Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014

Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Community Acquired Methicillin-Resistant Staphylococcus ...

  • Industries : Drug and Medication
  • Countries : United States, World
Muscular Dystrophy - Pipeline Review, H2 2014

Muscular Dystrophy - Pipeline Review, H2 2014

  • $ 2 000
  • Industry report
  • December 2014
  • by Global Markets Direct

Muscular Dystrophy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Muscular Dystrophy - Pipeline Review, H2 2014’, provides an overview of the Muscular Dystrophy’s therapeutic pipeline. ...

  • Industries : Pathology, Pharmaceutical
  • Countries : United States
Biomarker - 50 Global Experts R&D Centers Profiles

Biomarker - 50 Global Experts R&D Centers Profiles

  • $ 1 500
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : World
Biomarker - 50 European Experts & R&D Centers Profiles

Biomarker - 50 European Experts & R&D Centers Profiles

  • $ 1 500
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : Europe
Biomarker - 50 North American Experts & R&D Centers Profiles

Biomarker - 50 North American Experts & R&D Centers Profiles

  • $ 1 500
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : North America
Biomarker - 50 Eastern Asian Experts & R&D Centers Profiles

Biomarker - 50 Eastern Asian Experts & R&D Centers Profiles

  • $ 1 500
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : Asia
Biomarker - 30 Global Companies Profiles

Biomarker - 30 Global Companies Profiles

  • $ 1 250
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : World
Biomarker - 30 European Companies Profiles

Biomarker - 30 European Companies Profiles

  • $ 1 250
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : Europe
Biomarker - 30 North American Companies Profiles

Biomarker - 30 North American Companies Profiles

  • $ 1 250
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : North America
Biomarker - 30 Eastern Asian Companies Profiles

Biomarker - 30 Eastern Asian Companies Profiles

  • $ 1 250
  • Industry report
  • March 2015
  • by Expernova

A biomarker is a measurable indicator of whether a biological process is normal or not. An indicator and quantitative measure, it is most often a measurable protein in the blood or the presence of a molecule ...

  • Industries : Pathology, Genomics, General Medicine and Specialty Medicine
  • Countries : Asia
EKF Diagnostics Holdings plc (EKF) - Product Pipeline Analysis, 2015 Update

EKF Diagnostics Holdings plc (EKF) - Product Pipeline Analysis, 2015 Update

  • $ 750
  • Company report
  • February 2015
  • by Global Data

Summary EKF Diagnostics Holdings plc (EKF Diagnostics) is a medical device company. It designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, ...

  • Industries : Diagnostics, Diagnostics, Genomics, In Vitro Diagnostic, In Vitro Diagnostic, Pathology
  • Countries : United States, United Kingdom
Vital Signs - The Analyst%s Perspective - January 2015 Issue

Vital Signs - The Analyst%s Perspective - January 2015 Issue

  • $ 450
  • Industry report
  • February 2015
  • by Frost & Sullivan

This issue of Vital Signs, released on February 4, 2014, discusses Roche's collaboration with Foundation Medicine, Novartis' potential anti-aging drug, and DNA Electronics; acquisition of nanoMR, Inc.

  • Industries : Genomics
DNA Chip Research Inc. (2397) - Financial and Strategic SWOT Analysis Review

DNA Chip Research Inc. (2397) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • February 2015
  • by Global Data

Summary DNA Chip Research Inc. (DNA Chip) is a medical research organization. The company develops functional genomics based technologies and provides contract services. It offers contract service of data ...

  • Industries : Genomics
About 3 400 reports

Download Unlimited Documents from Trusted Public Sources

US - Country Risk

  • March 2015
    37 pages
  • Pathology  

    Oncology  

    Biomarker  

  • United States  

    Canada  

View report >

Global Rna Industry

March 2015

Global Rna Industry

March 2015

Dna Industry

March 2015

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.